The Holland based company ViCentra who built Kaleido is leveraging technology from Dexcom and Diabeloop to deliver the Hybrid Closed Loop system with the lightest insulin patch pump systems for managing type 1 diabetes.
The Hybrid Closed Loop system will deliver insulin using the DBLG1 algorithm which can receive information from the Dexcom G6 Continuous Glucose Monitoring (CGM) sensor. The DBLG1 algorithm is used by more than 10,000 users across Europe and by using real time data it can reduce hypoglycemia by more than 50%.
It will be housed in the Kaleido insulin pump which can be worn as a patch or placed in the user’s pocket and comes with two pumps. With the DBLG1 algorithm it can teach itself to adjust Kaleido’s insulin delivery for an optimised management of type 1 diabetes.
Related: Aloe Care Health introduces new medical alert device for older adults
Frans Cromme, Chief Executive Officer of ViCentra, said: “Kaleido with DBLG1 and Dexcom G6 improves users’ Time in Range by 16.7%, an achievement that should bring real benefits to people with type 1 diabetes. We are proud to deliver this game changing technology via a beautiful and small device, as we feel people deserve this when they need to rely on a medical device 24/7.”
Stephane Majerus, Chief Executive Officer of Diabeloop added: “This alliance between Diabeloop’s algorithm technology and the ViCentra pump aims to offer people with diabetes the benefits of the Kaleido design combined with our highly performing and proven algorithm.”
The Hybrid Closed Loop system is scheduled for distribution in 2024 in Germany, the Netherlands and France by ViCentra while distribution to the UK and Italy will be managed by Diabeloop.
